Microgravity disease models for Earth therapies: Junction Brief – November 2026

Acentric Research is produced with AI tools under human review. The authors are not financial professionals, and nothing here is investment advice or a recommendation to buy or sell any security. AI analysis can be wrong; check every claim against its cited source.

This Brief is an initial scan, not a full investigation. The method and scores behind it are in Biotechnology × Space in the Landscape Report.

Overview

Spaceflight causes marked loss of muscle and bone, and researchers say findings on it may apply to ageing, injury and illness on Earth. [1] Researchers use the International Space Station (ISS) to study that loss in animals and cells, in the hope of finding treatments for people on Earth. The European Space Agency (ESA) put it plainly in 2017: the medicine you take on Earth begins with cell research, and ISS experiments are helping to develop treatments for osteoporosis, eye diseases and muscle atrophy. [2]

What stands out is one mouse study. Mice treated in orbit with a decoy molecule that blocks two growth-limiting proteins kept their muscle and bone, researchers reported in September 2020. [1] The sources opened also report cautions, and name no drug in human trials that came from a space result. The dated sources run from 2017 to 2025, and later developments were not searched.

Current state

What the technology does. Animals or cells are flown, treated or observed in microgravity, and returned for analysis. ESA describes four experiments in its Columbus module of the ISS on muscle, retinal and stem cells, run on behalf of Italy's space agency to understand how to prevent cell death. In one, retinal cells were treated with coenzyme Q10 to see whether it counteracts the effects of radiation and microgravity; stem cells were included to see whether they could counter bone loss; another tested whether antioxidant nanoparticles help cells cope with stress. The samples were frozen on the station and returned to Earth for analysis, and the article gives no results. [2]

The mouse study. NASA describes Rodent Research-19 as an investigation of two molecular signalling pathways, myostatin and activin, that influence the breakdown of muscle and bone, studied as possible targets for keeping them healthy in spaceflight and aiding recovery afterwards. [3] ASBMB Today reports that 40 mice launched on 5 December 2019 for 33 days. Mice given an injected fragment of a receptor, which acts as a decoy for the two proteins, kept and gained muscle, and kept bone density, according to a study in the Proceedings of the National Academy of Sciences. Treated mice that had already lost muscle and bone recovered both after return to Earth. [1] The same article says the work might help people with muscle loss from age, injury or illness, and that the lead researcher hopes compounds that block activin A as well as myostatin will work better on the ground than earlier myostatin blockers, which he suspects are not enough alone. [1]

Brain-cell models. The National Stem Cell Foundation says it grows brain organoids from the cells of people with Parkinson's disease and primary progressive multiple sclerosis, with Alzheimer's organoids planned, and describes microgravity as an "accelerated environment" for studying neurodegenerative disease (the foundation's claims). A NASA award of $3.1 million funds three more missions through 2027. [4] Cedars-Sinai says its next work, funded by a new National Institutes of Health grant, uses microgravity to model accelerated inflammation and ageing in organ-chip models of the heart, gut and brain. [5]

How far it has come. Research with animals and cells. None of the sources opened reports a drug in human trials that came from an ISS result; ClinicalTrials.gov was not searched. [1][4]

Opportunities

The ASBMB article says the work could matter for bedridden people and people with cancer, chronic lung disease or other causes of muscle wasting, and quotes the lead scientist as saying there are many possible indications. [1] ESA says muscle, bone and eye problems may not concern most people on Earth, but this type of research makes better drugs and other measures possible. [2] Cedars-Sinai's investigators say they can create thousands of organoids in weeks to model disease and test drugs at a scale they could not reach otherwise. [5]

Challenges

  • Physics and engineering. The flights described carried limited samples; the ESA cells were incubated for seven days and the mice flew for 33. [2][1]
  • Regulation and evidence. An outside researcher quoted by ASBMB says space muscle loss differs from Earth-based forms, and another says several drug companies have tried to treat people with myostatin-blocking compounds without much success and that translation to humans is the open question. [1]
  • Capital and scale-up. The one award found is $3.1 million from NASA for three more missions; results of these flights were not searched for. [4]

Data sources

  • ISS National Laboratory and NASA research records, for flown experiments and results. [6]
  • NIH RePORTER, for federal grants. [7]
  • Europe PMC and PubMed, for the published studies such as the PNAS mouse paper, which this Brief did not open.
  • ClinicalTrials.gov, for any human study of a drug linked to a space result. [8]
  • No registry of microgravity disease-model outcomes was found.

Changelog

  • 2026-11-18: First published.

Sources

  1. Amber Dance, "Rodents in space: Keeping bone and muscle strong on the ISS", ASBMB Today, 2020-09-19 (society magazine reporting a study published in PNAS; the paper itself was not opened). asbmb.org (accessed 2026-11-18)
  2. European Space Agency, "Cells in space", 2017-12-07 (archive article). esa.int (accessed 2026-11-18)
  3. NASA, "Rodents and a Rocket Carried Researchers' Dreams into Space: Rodent Research-19" (agency article, 2019–2020). nasa.gov (accessed 2026-11-18)
  4. SatNews, "NASA awards National Stem Cell Foundation $3.1 million to continue studying the effects of microgravity on brain cells", 2025-03-27 (trade site reproducing the foundation's announcement; statements and claims are the foundation's). news.satnews.com (accessed 2026-11-18)
  5. Cedars-Sinai, "Cedars-Sinai Pioneering Creation of Organoids in Space", 2025-08-18 (institution release; statements about expected benefits are the investigators'). cedars-sinai.org (accessed 2026-11-18)
  6. ISS National Laboratory, research project portfolio. issnationallab.org (listed as a data source; the portfolio itself was not opened for this Brief)
  7. NIH RePORTER, project search. reporter.nih.gov (listed as a data source; not opened for this Brief)
  8. ClinicalTrials.gov, study search. clinicaltrials.gov (listed as a data source; not searched for this Brief)